Gong Y†, Hu N†, Ma L, Li W, Cheng X, Zhang Y, Zhu Y, Yang Y, Peng X, Zou D, Tian J, Yang L, Mei S, Wang X, Lo C. H., Chang J, Hou T, Zhang H, Xu B, Zhong R*, Yuan P*. ABTB2 Regulatory Variant as Predictor of Epirubicin-Based Neoadjuvant Chemotherapy in Luminal A Breast Cancer. Front Oncol. 2020; 10:571517. (*Corresponding author)
Release time:2022-11-25Hits:
Pre One:Deng Y, Wan H, Tian J, Cheng X, Rao M, Li J, Zhang H, Zhang M, Cai Y, Lu Z,.Li Y, Niu S, Shen N, Chang J, Fang Z*, Zhong R*. CpG-methylation-based risk score predicts progression in colorectal cancer. Epigenomics. 2020; 12(7):605-615. (*Corresponding author)
